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Abstract
Protein kinase C-e (ePKC) induces neurite outgrowth in
neuroblastoma cells but molecular mechanism of the ePKC-
induced neurite outgrowth is not fully understood. Therefore,
we investigated the ability of phosphatidylinositol 4,5-bis-
phosphate (PIP2) binding of ePKC and its correlation with the
neurite extension. We found that full length ePKC bound to
PIP2 in a 12-o-tetradecanoylphorbol-13-acetate dependent
manner, while the regulatory domain of ePKC (eRD) bound to
PIP2 without any stimulation. To identify the PIP2 binding
region, we made mutants lacking several regions from eRD,
and examined their PIP2 binding activity. The mutants lacking
variable region 1 (V1) bound to PIP2 stronger than intact
eRD, while the mutants lacking pseudo-substrate or common
region 1 (C1) lost the binding. The PIP2 binding ability of the
V3-deleted mutant was weakened. Those PIP2 bindings of
ePKC, eRD and the mutants well correlated to their neurite
induction ability. In addition, a chimera of pleckstrin homology
domain of phospholipase Cd and the V3 region of ePKC
revealed that PIP2 binding domain and the V3 region are
sufﬁcient for the neurite induction, and a ﬁrst 16 amino acids
in the V3 region was important for neurite extension. In
conclusion, ePKC directly binds to PIP2 mainly through
pseudo-substrate and common region 1, contributing to the
neurite induction activity.
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Protein kinase C (PKC) plays pivotal roles in proliferation,
differentiation, and apoptosis etc. The PKC family consists
of at least 10 subtypes that are classiﬁed into three groups
based on the structure of their regulatory domain (RD)
(Nishizuka 1992; Shirai and Saito 2002; Newton 2006).
Conventional PKCs (a, b1, b2, and c) have two common
regions, C1 domain and C2 domain, in the RD. The former is
responsible for diacylglycerol (DAG) and phorbol ester
binding, the latter binds to calcium. Thus, calcium and DAG
are required for the activation of conventional PKCs. On the
other hand, novel PKCs (e, d, g, and h) are activated by
DAG, but not by Ca
2+ because novel PKCs lack the C2
domain. Atypical PKCs (f and k/i) are insensitive to both
Ca
2+ and DAG because of lack of the C2 domain and one of
the C1 domains. Each subtype shows different enzymatic
properties and distinct tissue and cellular distribution,
suggesting speciﬁc functions of each PKC subtype (Ohno
1997), but the individual functions have not been fully
understood.
Among them, ePKC is abundant in the central nervous
system and is thought to play important roles in nervous
system (Tanaka and Nishizuka 1994; Akita 2002). Speciﬁc-
ally, ePKC is localized at nerve terminus and seems to
mediate synaptic function (Saito et al. 1993; Prekeris et al.
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neural differentiation with various stimulations (Hundle et al.
1995; Zeidman et al. 1999). For the neurite-induction ability,
the actin-binding site (ABS) between the ﬁrst half of C1
domain (C1A) and second half of C1 domain (C1B) is
important (Prekeris et al. 1996, 1998; Zeidman et al. 2002).
Interestingly, it has been shown that the neurite-induction
ability of ePKC is independent of its catalytic activity;
regulatory domain of ePKC (eRD) also induces neurite
outgrowth (Zeidman et al. 1999). However, in the case of the
eRD-mediated neurite induction, deletion of ABS is not
effective; RD of an ABS-deleted mutant still had strong
neurite induction ability, while full length of the ABS-deleted
mutant had about 50% less activity (Zeidman et al. 2002).
These results suggest that there is an additional factor, in
addition to actin binding, important for the neurite induction
by ePKC, especially by eRD.
Phosphatidylinositol 4,5-bisphosphate (PIP2) is membrane
phospholipids. It is well established that PIP2 is involved in
the regulation of the action through regulating actin-binding
proteins (Toker 1998). To date, many actin-binding proteins
which can bind to PIP2 have been reported (Toker 1998;
Gorbatyuk et al. 2006). In addition, phospholipids including
PIP2 can activate some PKC including ePKC (Toker et al.
1994) and direct interactions of phospholipids to some PKCs
have been reported (Huang and Huang 1991; Sanchez-
Bautistra et al. 2006). However, there is no direct evidence
that ePKC binds to PIP2. We, therefore, investigated the
possibility of the direct binding of ePKC to PIP2 and its
correlation with the neurite outgrowth.
Materials and methods
Materials
SH-SY5Y cells were purchased and fetal bovine serum was
obtained from Riken cell bank (Tokyo, Japan) and Sigma (St Louis,
MO, USA), respectively. FuGENE 6 transfection reagent (Roche
Molecular Biochemicals, Indianapolis, IN, USA) and PIP2 were
obtained from Roche Molecular Biochemicals. Rabbit anti-green
ﬂuorescent protein (GFP) antibody was produced by us. GFP–fused
pleckstrin homology domain (PHD) of phospholipase Cd (PLCd),
named GFP–PHD here, was kindly donated by Dr Iino and Hirose
et al. (1999).
Cell culture
SH-SY5Y cells were cultured in Dulbecco’s modiﬁed Eagles’
medium (Nacali tesque, Kyoto, Japan) and Dulbecco’s modiﬁed
Eagles’ medium/Ham’s F-12 medium (1 : 1) (GIBCO, Grand
Island, NY, USA) at 37 C in humidiﬁed atmosphere containing
5% CO2. The media contained 25 mmol/L glucose, and were
buffered with 44 mmol/L NaHCO3 and supplemented with 10%
fetal bovine serum (Sigma), 1% GlutaMAX
TM-I (Invitrogen Corp.,
Carlsbad, CA, USA), penicillin (100 units/mL) and streptomycin
(100 lg/mL) (Invitrogen Corp.).
Constructs of plasmids encoding GFP-fused ePKC and mutants
The plasmid encoding ePKC having GFP at its C terminus [full
length ePKC (eFL)–GFP] was described previously (Shirai et al.
1998). A cDNA fragments encoding eRD with Bgl II site was
produced by a PCR with cDNA for rat ePKC as the template. The
sense primer was 5-TTAGATCTACCATGGTAGTGTTCAATG-
GCC-3, and the anti-sense was 5-GAAGATCTTCCTCGGTTGTC-
AAATGAC-3. The PCR product was subcloned into pTB701-GFP
(described as BS340 in Shirai et al. 1998) for the expression in
mammalian cells and into pGEX-4T-1 (Amersham Pharmacia
Biotech, Buckinghamshire, UK) for bacterial expression of a
glutathione S-transferase (GST)-fusion protein, respectively. The
plasmids encoding mutants lacking variable region 1 (DV1), pseudo-
substrate (DPS) region, C1, C1A, C1B domains, and V3 region were
made using the amino terminus-deleted and domain-deleted mutants
of ePKC described by Kashiwagi et al. (2002) as the template and
primers described above. Similarly, PCR was performed using
following primers to make mutants lacking some of V3 regions, and
subcloned into Bgl II site of BS340. Anti-sense primers were 5-
TTAGATCTTTCCTGGTCACAAGGGGA-3 for RRKK mutant II,
5-GAAGATCTTGACTTGGATCGGTCGTCTTC-3 for RRKK
mutant, and 5-TTAGATCTTGGCCACTGTTGAT-3 for DRRKK,
respectively. Furthermore, a site directed mutagenesis was per-
formed according to manufacture’s recommended protocol with
ExSite PCR-based site directed mutagenesis kit (Stratagene, La
Jolla, CA, USA) to make the putative actin-binding site-D (DpABS)
mutant. Rat ePKC cDNA was used as a template and the primers
used were 5¢-ATCAACAACATCCGGAAGGCC-3¢ and 5¢-
ATCTTCCTGGTCACAAGGGGA-3¢. All PCR products were
veriﬁed by sequencing.
Constructs of plasmids encoding a chimera of PH domain of
PLCd and the V3 region of ePKC
A cDNA fragment encoding the V3 region of rat ePKC with
Xho I sites were produced by PCR using the sense primer,
5-TTTCTAGAGGGGTGGACGCCAGAGGAATT-3, and the anti-
sense primer, 5-CCGGGCCCTTATCCTCGGTTGTCAAATGA-3.
A cDNA encoding PH domain was obtained by digestion of
GFP–PHD by with Bam HI and Xho I. The PCR product of the
ePKC V3 region and the cDNA encoding PHD were subcloned into
pEGFPC1 (Clontech, Palo Alto, CA, USA). The PCR product was
veriﬁed by its sequencing.
Transfection and confocal microscopy
Cells (2.0 · 10
6 cells/dish) on glass-bottom dish (MatTek Corp.,
Ashland, MA, USA) were transfected using 6 lL of FuGENE
TM6
transfection reagent (Roche Molecular Biochemicals) and 2 lgo f
DNA according to the manufacturer’s protocol. Transfected cells
were cultured at 37 C for about 24 h before use. The ﬂuorescence of
GFP was observed under confocal laser scanning ﬂuorescent
microscopy (Carl Zeiss, Jena, Germany). The GFP-ﬂuorescence
was monitored at 488 nm argon laser excitation with 515 nm long
pass barrier ﬁlter.
Evaluation of neurite induction
Twenty-four hours after the transfection, at least 100 cells
expressing the GFP-fused ePKC or mutants were observed under
confocal laser microscopy and the cells with neurites longer than the
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experiments were performed and data (mean + SEM) are presented
as percentage of the cells having long neurites among the 100 cells
expressing GFP-fused ePKC or mutants
Recombinant protein expression and puriﬁcation
BL21 (DE3) pLys cells were transformed with the plasmids for
GST–eRD and control vector according to the manufacture’s
instruction (New England Biolabs, Beverly, MA, USA), and the
expression of recombinant proteins was induced by 0.1 mmol/L
isopropyl-1-thio-b-D-galactoside at 25 C for 4 h. The cells were
then harvested and lysed in column buffer [20 mmol/L Tris–HCl
(pH 7.0), 1 mmol/L EDTA, 1 mmol/L dithiothreitol, 5 mmol/L
MgCl2, 250 mmol/L sucrose, 1% triton-X 100, 20 lg/mL leupeptin,
and 1 mmol/L phenylmethylsulfonyl ﬂuoride] with handy sonic
(Tomy Seiko Co., Ltd, Tokyo, Japan). After ultra-centrifugation at
14 000 g for 30 min, the proteins were puriﬁed using Glutathione-
Sepharose 4B (Amersham Pharmacia Biotech) according to the
manufacture’s instruction.
Protein-lipid overlay assay
Various amount of PIP2 (2–500 pmol) were spotted on Hybond-C
extra membrane (Amersham Biosciences). After dried up, the
membrane was blocked with 3% fatty acid-free bovine serum
albumin in Tris buffered saline with Tween 20 (TBST; 50 mmol/L
Tris–HCl, 150 mmol/L NaCl, and 0.1% Tween 20, pH 7.5) for 1 h
at 25 C, and then incubated with 20 nmol/L GST–RDePKC or GST
for 3 h at 25 C in the blocking solution. The membrane was washed
ﬁve times for 1 h (each time) in TBST buffer and then incubated
for 1 h with 1/1000 dilution of anti-GST polyclonal antibody
(Sigma-Aldrich) in the blocking solution. After washing with TBST,
the membrane was immersed in the blocking solution with anti-
rabbit horseradish peroxidase conjugate (1/5000 dilution) (Jackson
ImmunoResearch Laboratories, West Grove, PA, USA) for 1 h.
After washing, the protein bound to the lipid was detected by
enhanced chemiluminescence (Amersham Biosciences).
In the case of protein-lipid overlay (PLO) assay using GFP fusion
proteins, we used lysate of COS-7 cells, which were transfected with
various plasmids encoding ePKC and the mutants. The amount of
the fusion proteins to be applied to the PLO assay was adjusted by
western blot using GFP antibody.
Results
Effect of over-expression of ePKC on neurite extension
First, we tried to conﬁrm the neurite induction by over-
expression of ePKC in SH-SY5Y cells. Approximately 20%
of the cells expressing eFL–GFP had long neurites, while
only 5% of control cells expressing GFP showed long
processes (Fig. 1b). eFL–GFP was expressed mainly in the
cytoplasm under the normal conditions but TPA treatment
induced translocation of eFL–GFP to the plasma membrane
(Fig. 1c), resulting in the neurite extension; about 50% of the
eFL–GFP cells possessed long neurites in the presence of
TPA (Fig. 1b). Typical long neurite induced by ePKC had
one or two neurites with varicose structures (Fig. 1c).
By contrast, eRD–GFP showed membrane localization
and strong neurite-induction activity even in the absence of
TPA (Fig. 1b and c); 35% of the eRD cells had the typical
long neurite. These results are basically consistent with
previous ﬁndings by Larsson’s group.
To investigate the importance of actin-binding site
between C1A and C1B in the neurite induction by eRD,
we made a K/A mutant, in which lysine in the consensus
sequence of the actin-binding site was substituted by alanine.
RD of the K/A mutant showed both strong neurite induction
activity and membrane localization as shown in Fig. 1b and
c; about 35% of the cells expressing RD of the K/A mutant
possessed long neurites. These results suggested that, except
for the actin-binding site, unknown important factor is
involved in the eRD-induced neurite induction
PIP2 binding of ePKC
We, then, focused on PIP2 as a possible candidate for the
important regulator of the eRD-induced neurite induction as
described above. To examine whether ePKC can bind to
PIP2, PLO assay was employed using GFP-fusion proteins
from COS-7 cell lysate. eRD–GFP clearly binds to PIP2 as
well as PH domain of phospholipase Cd, which is well
known to speciﬁcally bind to PIP2 (Fig. 2a). To conﬁrm that
eRD–GFP directly binds to PIP2, puriﬁed recombinant
protein of GST–tagged eRD (GST–eRD) was used in the
PLO assay. Similarly to the GFP-fusion protein form COS-7
cell lysate, the puriﬁed protein bound to PIP2 in a dose-
dependent manner (Fig. 2b), indicating eRD can directly
bind to PIP2 without any additional factors. By contrast, eFL
did not show PIP2 binding under the same conditions. We,
then, performed PLO assay in the presence of TPA because
TPA induced the membrane localization of ePKC and neurite
outgrowth as shown in Fig. 1. As expected, the TPA
treatment enabled eFL to bind to PIP2 (Fig. 2c).
To identify the responsible region for the PIP2 binding, we
made a series of mutants and investigated their PIP2 binding
(Fig. 3). A mutant lacking V1 region from RD (DV1–GFP)
showed stronger PIP2 binding than eRD–GFP, while deletion
of V3 region weakened the PIP2 binding. Deletion of either
PS or C1 domain completely abolished the PIP2 binding,
indicating there is PIP2 binding region(s) in the PS and C1
domains. Furthermore, to investigate which domain, C1A or
C1B, is critical for the PIP2 binding, we made C1A or C1B-
deleted mutants. DC1A–GFP very faintly bound to PIP2,
while DC1B–GFP lost the PIP2 binding. These results
suggest that PS and C1 regions, relatively C1B than C1A,
are important for the PIP2 binding.
Importance of PIP2 binding for the neurite induction
Next, the effects of over-expression of the deletion mutants on
neurite induction were examined. DV1–GFP showed stronger
neurite-induction activity than eRD–GFP; 60% of cells
PIP2 binding and neurite extension ability of ePKC 1637
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On the other hand, DPS, DC1, DC1A, DC1B–, and DV3–GFP
lost ability to induce long neurite (Fig. 4). Localization of the
mutants was also investigated. DV1–GFP showed very clear
membrane localization, while DPS, DC1, DC1A, and DC1B–
GFP were cytosolic. DV3–GFP was localized on the nuclear
membrane with perinuclear accumulation, in addition to weak
plasma membrane localization (Fig. 5).
Table 1 summarizes the results of localization, PIP2
binding activity and neurite induction activity, indicating
that the mutants without PIP2 binding activity clearly lost
membrane location and neurite induction. On the other hand,
the mutant having stronger PIP2 binding activity showed
enhanced neurite induction ability. These results demonstra-
ted that PIP2 binding is indispensable and important for the
membrane localization and neurite induction of ePKC. In
addition, as seen in the result of DV3–GFP, moderate PIP2
binding was not enough for the neurite induction, suggesting
that strong PIP2 binding and/or V3 region are necessary.
To conﬁrm the importance of the PIP2 binding and V3
region for the neurite induction, we made a chimera of PH
domain of PLCd and V3 region of ePKC (PHD–eV3) and
compared its neurite induction ability with that of PHD
alone. Approximately 10% of the cells expressing PHD
possessed long neurites, while 28% of the cells having PHD–
eV3 showed comparable neurite induction ability to the eRD,
Fig. 1 Induction of neurite outgrowth by over-expression of protein
kinase C-e (ePKC) and mutants. (a) Schematic illustration of full length
ePKC (eFL), regulatory domain of ePKC (eRD) and regulatory domain
of K/A mutant. Lysine in the actin-binding site of the K/A mutant was
substituted by alanine. Consensus amino acids in the actin-binding
motif were written in red. (b) Statistic analysis on the neurite induction
ability of ePKC and the mutants. Twenty-four hours after the trans-
fection, the cells with neurites longer than the length of two cell bodies
were counted as described in Materials and methods. Three inde-
pendent experiments were performed and the data (mean + SEM) are
presented as percentage of the cells having long neurites among the
cells expressing green ﬂuorescent protein (GFP)-fused ePKC or mu-
tants. (c) Typical neurites induced by GFP-tagged eFL, regulatory
domain of ePKC (eRD), and KA mutant in the presence or absence of
12-o-tetradecanoylphorbol-13-acetate (TPA) and their localizations.
Plasmids encoding GFP-tagged eFL, eRD, and KA mutant were
transfected into SHSY-5Y cells by lipofection and images were taken
after 24 h after the transfection. Bars are 20 lm. (d) Magniﬁed images
of SH-SY5Y cells expressing GFP-tagged eFL, eRD, or KA mutant.
The images shown in (c) are magniﬁed to clearly show the plasma
membrane localization of GFP–eFL in the presence of TPA, and of
eRD or KA mutant without any stimulation. Bars are 20 lm.
1638 Y. Shirai et al.
Journal Compilation   2007 International Society for Neurochemistry, J. Neurochem. (2007) 102, 1635–1644
  2007 The Authorsalthough both proteins showed membrane localization
(Fig. 6). These results indicate PIP2 binding and V3 region
are sufﬁcient for the neurite induction.
Identiﬁcation of subregion in the V3 region important for
the neurite induction
To identify subregion(s) of the V3 region important for the
neurite induction, we focused on two regions; that are a
cluster of basic amino acids corresponding to amino acids
from 319 arginine to 322 lysine (RRKK) and a putative ABS
Fig. 2 Phosphatidylinositol 4,5-bisphosphate (PIP2) binding of protein
kinase C-e (ePKC). (a) Binding of regulatory domain of ePKC (eRD) to
PIP2. Various amount of PIP2 were spotted on the membrane and
protein-lipid overlay (PLO) assay was performed using lysates from
COS-7 cells expressing eRD–green ﬂuorescent protein (GFP) or full
length ePKC (eFL)–GFP. GFP and GFP–pleckstrin homology domain
(PHD) of PLCd were used as negative and positive control, respect-
ively. (b) Direct binding of eRD to PIP2. Puriﬁed GST–eRD (10 nmol/L)
was used for PLO assay to show direct binding. Same concentration of
puriﬁed glutathione S-transferase (GST) was used as negative control.
(c) 12-o-tetradecanoylphorbol-13-acetate (TPA)-dependent PIP2
binding of full length ePKC (eFL). PLO assay was performed using
lysates from COS-7 cells expressing eFL–GFP or GFP in the presence
and absence of 200 nmol/L TPA.
Fig. 3 Schematic illustration and phosphatidylinositol 4,5-bisphos-
phate (PIP2) binding ability of the domain-deleted mutant of protein
kinase C-e (ePKC). Protein-lipid overlay (PLO) assay was performed
using lysates from COS-7 cells expressing green ﬂuorescent protein
(GFP)-fused regulatory domain of ePKC (eRD), and deletion mutants
of variable region 1 (DV1), pseudo-substrate (DPS), common region 1-
D (DC1), ﬁrst half of C1 domain (DC1A), second half of C1 domain
(DC1B), and DV3.
Fig. 4 Neurite induction ability of the domain-deleted mutant of pro-
tein kinase C-e (ePKC). Twenty-four hours after the transfection
of respective plasmids, the cells with neurites longer than the length
of two cell bodies were counted. Three independent experiments were
performed and at least 100 cells were counted at every experiment.
Data (mean + SEM) are presented as percentage.
PIP2 binding and neurite extension ability of ePKC 1639
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glutamic acid (pABS), which has consensus actin-binding
motif LKXXEX (Fig. 7a). We made a series of the mutants as
shown in Fig. 7b and compared their neurite induction ability.
Both RRKK and RRKK II mutants showed about 30% less
neurite induction ability compared with the eRD; about 25%
of the cells expressing the RRKK and RRKK II mutants had
typical neurites. The PIP2 binding of RRKK was slightly
weaker than eRD but were strongly enough (Fig. 8a). The
PIP2 binding of RRKK II mutant was similar to that of RRKK
mutant This suggested that pABS is somehow important for
the neurite induction and PIP2 binding, because both RRKK
and RRKK II mutants lack pABS. Consistently with this, the
ability of the pABS deletion mutant to induce the neurite and
its PIP2 binding was lower than that of eRD and similar to
those of RRKK and RRKK II (Figs 7 and 8). On the other
Fig. 5 Localization of the domain-deleted
mutant of protein kinase C-e (ePKC). Plas-
mids encoding green ﬂuorescent protein
(GFP)-tagged mutants deleted variable
region 1 (DV1), pseudo-substrate (DPS),
common region 1-D (DC1), ﬁrst half of C1
domain (DC1A), second half of C1 domain
(DC1B), and DV3 were transfected into
SHSY-5Y cells by lipofection and images
were taken after 24 h after the transfection.
Bars are 20 lm.
Table 1 Correlation between the phosphatidylinositol 4,5-bisphos-
phate (PIP2) binding, the plasma membrane localization, and the








ePKC without TPA No No 20%
ePKC without TPA ++ Yes 50%
Wild RD ++ Yes 35%
RDK/A ++ Yes 35%
RD DV1 +++ Yes 60%
RD DPS No No 6%
RD DC1 No No 5%
RD DC1A Very faint No 6%
RD DC1B No No 2%
RD DV3 + Weak 5%
+++ and + represents stronger and moderate PIP2 binding, respect-
ively. TPA, 12-o-tetradecanoylphorbol-13-acetate; V1, variable
regions 1 and 3; PS, pseudo-substrate; C1, common region 1; C1A,
ﬁrst half of C1 domain; C1B, second half of C1 domain; RD, regulatory
domain.
Fig. 6 Effect of pleckstrin homology domain (PHD) of phospholipase
C-d (PLCd) and the variable region 3 (V3) of protein kinase C-e (ePKC)
on neurite induction. (a) Localization of green ﬂuorescent protein
(GFP)–PHD and GFP–PHDeV3 in SY-SY5Y cells. Bars are 20 lm. (b)
Statistical analysis on the neurite induction ability of GFP–PHD and
GFP–PHDeV3. Twenty-four hours after the transfection, the cells with
neurites longer than the length of two cell bodies were counted. Three
independent experiments were performed and at least 100 cells were
counted at every experiment. Data (mean + SEM) are presented as
percentage. *p < 0.05.
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(DRRKK) did not signiﬁcantly affect on the neurite induction
ability and the PIP2 binding (Fig. 7). However, when further
16 amino acids were deleted from DRRKK mutant lost the
neurite induction ability. The localization of these mutants
was also investigated. As shown in Fig. 8b, DpABS and
RRKK mutant were localized on the plasma membrane. The
localization of RRKK II mutant was similar to that of RRKK
mutant (data not shown). Some cells expressing DRRKK
showed the nuclear membrane localization in addition to the
plasma membrane localization like DV3 mutant (Fig. 8b),
suggesting the basic amino acids are important for the plasma
membrane localization.
These results revealed that the ﬁrst 16 amino acids of the
V3 region are important for the neurite induction and
conﬁrmed the importance of the PIP2 binding on the neurite
induction.
Discussion
This is a ﬁrst report to show that ePKC directly binds to PIP2.
There are two types of interaction between PIP2 and proteins.
One is the case that some proteins interact with the
phosphoinositide through distinct domains including PH
domain, FYVE, and ENTH, etc (DiNitto et al. 2003). The
other case is that partner proteins bind to the lipid through an
electrostatic mechanism involving basic amino acids. Gen-
erally, it is considered that the former interaction is more
speciﬁc than the latter’s, although there are varieties of the
speciﬁcity even in the case of the interaction between the
distinct lipid-binding domains and PIP2 (DiNitto et al. 2003).
Looking at the responsible region of ePKC for the PIP2
binding, speciﬁc motives for phosphoinositides like PH or
ﬁve domains are not found, suggesting that electrostatic
mechanism of basic amino acids are involved in the PIP2
binding of ePKC. Indeed, the PS and C1 regions of ePKC
contain many basic amino acids and mutations on some of
them reduced the PIP2 binding (data not shown). Especially,
a number of basic amino acids in the PS region of ePKC are
prominent among PKCs. Alternatively, higher structure of
the C1 domain may be important as its structure is critical for
DAG binding (Kazanietz et al. 1995; Xu et al. 1997). NMR
and crystallography of the PS and C1 with PIP2 would be
informative to understand precise mechanism of the PIP2
interaction. In the meantime, the characteristics of the PIP2
binding sites suggest that ePKC may bind to another
phospholipids including PIP3. Interestingly, the regulations
of ePKC by PIP3 have been reported (Toker et al. 1994;
Moriya et al. 1996).
We also showed that the PIP2 binding ability of ePKC
and mutants well correlated to their neurite induction
abilities. For example, eFL induced neurites and bound to
PIP2 in the presence of TPA, while any stimulation was not
necessary for neurite induction and the PIP2 binding of
eRD. In addition, the PIP2 binding abilities of the domain-
deleted mutants of ePKC were parallel to their neurite
induction abilities (Table 1 and Fig. 8). These results
indicate that the PIP2 binding is important for the neurite
induction. However, the PIP2 binding was not sufﬁcient for
the neurite outgrowth because PH domain of PLCd did not
induce the neurite outgrowth in SHSY-5Y cells. For the
neurite induction, the V3 region of the ePKC was
additionally necessary. It is evident that the V3 region
Fig. 7 Neurite induction ability of the protein kinase C-e (ePKC) mu-
tants lacking some of variable region 3 (V3). (a) V3 region of rat ePKC
consists of 81 amino acids including a cluster of basic amino acids
RRKK and putative actin-binding motif, LKELE. (b) Schematic illus-
tration of the mutants. RK and putative actin-binding site (pABS)
represent the cluster of basic amino acids and the putative actin-
binding site in the V3 region, respectively. The numbers at the right
side indicates the numbers of deleted amino acids from the V3 region.
(c) Statistical analysis on the neurite induction ability of regulatory
domain of ePKC (eRD) and the mutants. Twenty-four hours after the
transfection, at least 100 cells expressing respective mutants were
observed and the ratios of the cells with neurite longer than the length
of two cell bodies to all observed cells were represented as percent-
age. Data are presented as mean ± SEM in three independent
experiments. *Indicates the difference between eRD and the
respective mutants was signiﬁcant (p < 0.05). **Indicates the differ-
ence between DV3 and DRRKK was signiﬁcant (p < 0.05).
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V3 regions, for example, DPS and DC1 lost the ability to
induce neurite outgrowth. These results clearly show that
both the PIP2 binding and ePKC V3 region are necessary
and sufﬁcient for the neurite induction. Importantly, the
results using PHD–eV3 also proved that, at least, PIP2 is
responsible lipid for the neurite induction even if ePKC
could bind to another phospholipids, based on that PH
domain of PLCd speciﬁcally binds to PIP2.
In the V3 region of rat ePKC, we found pABS and it
seemed to be somehow important for the neurite induction
ability because deletion of the pABS reduced the ability
about 20%. We, therefore, investigated whether the pABS
binds to actin by ELISA and Biacore 3000 (GE Healthcare,
Buckinghamshire, UK) using puriﬁed GST-fusion protein of
the V3 region (GST–eV3) and pABS deleted one (GST–
eV3DpABS). Unfortunately, however, we could not conclude
that the V3 region binds to actin through the pABS because
both GST–eV3 and GST–eV3DpABS showed tendency to
bind to actin and the interaction was not so signiﬁcant (data
not shown). In addition, the pABS is not conserved in human
ePKC although it is seen in mouse ePKC; the corresponding
sequence of human is insufﬁcient as actin-binding motif. In
spite of this, human ePKC also induces the neurite. These
facts suggest that pABS does not functions as ABS. Rather,
the ﬁrst 16 amino acids in the V3 region are important for the
neurite induction of eRD. The importance of these amino
acids for neurite induction is supported by Ling et al. (2005);
they showed ﬁrst 20 amino acids of V3 region are critical for
the neurite induction ability of human ePKC.
Furthermore, plasma membrane localization appears to be
important for the neurite induction for ePKC because all
mutants which induced neurite outgrowth were localized on
the plasma membrane, consistent with previous results
Fig. 8 Phosphatidylinositol 4,5-bisphos-
phate (PIP2) binding ability and localization
of the protein kinase C-e (ePKC) mutants
lacking some of variable region 3 (V3). (a)
Protein-lipid overlay (PLO) assay was per-
formed using lysates from COS-7 cells
expressing green ﬂuorescent protein
(GFP)-fused Dputative actin-binding site
(pABS), RRKK mutant, or DRRKK. Regu-
latory domain of ePKC (eRD) and GFP were
used as positive and negative control,
respectively. (b) Plasmids encoding GFP-
tagged DpABS, RRKK mutant, or DRRKK
were transfected into SHSY-5Y cells by
lipofection and images were taken after
24 h after the transfection. Upper images
are magniﬁed ones. Upper panels are
magniﬁed images. Bars are 20 lm.
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mutants, which lost the neurite induction activity, showed
nuclear and Golgi membrane localization in addition to weak
plasma membrane localization, suggesting V3 region and
PIP2 binding may contribute to the membrane localization.
Indeed, importance of a cluster of basic amino acids, RRKK,
in the V3 region was shown (Fig. 8). However, the plasma
membrane localization and the PIP2 binding were not
sufﬁcient for the neurite induction because GFP–PHD did
not induce neurite although it localizes on the plasma
membrane. These ﬁndings suggest recruitment of ePKC to
speciﬁc site on the plasma membrane may be important for
the neurite induction.
How do the PIP2 binding and the V3 region, especially the
ﬁrst 16 amino acids, participate in the neurite outgrowth?
What we can do here is only speculation. One plausible
function of the PIP2 binding of ePKC is to regulate the
amount of PIP2 at local sites of the membrane. This may
inﬂuence the function of actin-binding proteins, resulting in
actin rearrangement and neurite induction. Other possibility
is that the PIP2 binding of ePKC contributes to the inhibition
of the ROCK-Rho A path way because Larsson’s group
reported that Rho A and ROCK are involved in the eRD-
induced neurite outgrowth (Trolle ´r et al., 2004). Indeed,
PIP2 activates Rho A by regulating open state of RhoA/
RhoGDI complex (Faure et al., 1999). The PIP2 binding of
ePKC may affect on this state by reducing amount of free
PIP2 at speciﬁc site. On hand, the V3 region may bind to
some proteins, the regulating RhoA/ROCK pathway and
contributing to the recruitment of ePKC to appropriate site. A
GTPase-activating protein for the Rho family, p190RhoGAP,
is one interesting candidate to bind to the V3 because it binds
to ePKC (Ling et al. 2005) and is relating to the regulation of
Rho A. Intriguingly, the accumulation of p190 RhoGAP in
lipid rafts regulates Rho activity, affecting in cytoskeletal
structure (Mammoto et al. 2006). As discussed, the mech-
anism of ePKC-induced neurite induction is still puzzling but
the PIP2 binding would be one piece to solve the puzzle, in
addition to several proteins including actin, actin-binding
proteins, Rho A, and Rho-regulating proteins as reported by
Larsson group.
In conclusion, ePKC binds to PIP2 through the PS and C1
regions, contributing its neurite induction ability cooperating
with the V3 region. The PIP2 binding gives new insight to
understand mechanisms of ePKC functions including the
neurite induction.
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